Nuvo Pharmaceuticals Inc NRIFF

RE:RE:And the answer is...

[longondmx]

Just to clarify - was the thought relating to the split as follows: - Management suspects NRI is a buyout target. With the buyout, no more employment. So, before being bought out split the company into two. 1) New NRI and 2) Crescita. When NEW NRI is bought out, management can continue to be employed in Crescita. Crescita will be the new DMX (a play on pipelines that will keep people employed for another while). All the while, diluting the company and shareholders of any value. Is that what some think? If so, surprised Crescita is not tanking further. I guess the cash it has is keeping it buoyed for a while. Looks like it is hovering shy of $2 as that is the price that accounts for the safety of the cash transferred to it less the high risk of continued cash burn/no real prospects. The $2 price will only diminish over time. The current NEW NRI shareprice of $5+ reflects the elimination of the drag that the pipeline placed on old Nuvo. So, looks like the split may settle around $5+ NRI and sub $2.00 Crescita? Still better than what we closed off on Friday - but barely. problem is that the Crescita stock price may find pressure in the coming days as shares become available in people's accounts.